Acemannan’s immunostimulant activity is thought as a result of inducing increases in TNF-alpha and IL-1. At injection sites, increased lymphocytic infiltration and accumulation have been noted. In tissue cultures, acemannan has suppressed HIV replication.
Veterinary acemannan injection is labeled for use in dogs or cats as an aid in the treatment ( _i.e.,_ surgery) and clinical management of fibrosarcoma. It has been used to treat FeLV, FIV, and FIP infections in cats but clinical efficacy has not been adequately proven by controlled clinical studies. It reportedly has been used in horses, but no specific information on this was located.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）